1. Home
  2. DRMA vs SINT Comparison

DRMA vs SINT Comparison

Compare DRMA & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

HOLD

Current Price

$1.21

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$2.75

Market Cap

11.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRMA
SINT
Founded
2014
1996
Country
United States
United States
Employees
8
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
11.7M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
DRMA
SINT
Price
$1.21
$2.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$10.00
$16.00
AVG Volume (30 Days)
1.8M
28.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,887,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$80.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.90
52 Week Low
$0.59
$1.72
52 Week High
$7.33
$6.78

Technical Indicators

Market Signals
Indicator
DRMA
SINT
Relative Strength Index (RSI) 43.20 39.33
Support Level $1.11 $2.58
Resistance Level $2.29 $2.94
Average True Range (ATR) 0.08 0.13
MACD 0.04 0.02
Stochastic Oscillator 56.25 25.00

Price Performance

Historical Comparison
DRMA
SINT

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology for patients suffering with acne. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin.

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Share on Social Networks: